Mondrian Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$75.5M |
| 2 |
Colgate-Palmolive
CL
|
+$31.2M |
| 3 |
PPG Industries
PPG
|
+$14.5M |
| 4 |
Banco Santander
SAN
|
+$14.1M |
| 5 |
ExxonMobil
XOM
|
+$11.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$60.7M |
| 2 |
EMBJ
Embraer S.A. ADS
EMBJ
|
+$47.2M |
| 3 |
Pfizer
PFE
|
+$44.6M |
| 4 |
RB Global
RBA
|
+$37.7M |
| 5 |
Itaú Unibanco
ITUB
|
+$36.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 23.32% |
| 2 | Financials | 20.52% |
| 3 | Technology | 17.58% |
| 4 | Healthcare | 12.94% |
| 5 | Energy | 7.13% |
Similar funds
Mondrian Investment Partners's Q3 2018 Portfolio in Review
As of Q3 2018, Mondrian Investment Partners held 128 positions worth $3.19B, down 6.8% from $3.42B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Mondrian Investment Partners withdrew a net $243M in Q3 2018, closing 6 positions and reducing 39 holdings. Its most notable exit was UnitedHealth, an estimated $60.7M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 23% of assets, down from 29% a quarter earlier, followed by Financials and Technology.
Against the trend, Mondrian Investment Partners opened a new position in Colgate-Palmolive worth $31.3M.
- Mondrian Investment Partners's largest Q3 2018 buy was Colgate-Palmolive: 467,977 shares worth $31.3M.
- Mondrian Investment Partners added most to Johnson & Johnson in Q3 2018, an estimated $75.5M increase.
- Mondrian Investment Partners's biggest Q3 2018 reduction was Embraer S.A. ADS, cutting an estimated $47.2M.
- Mondrian Investment Partners fully exited UnitedHealth in Q3 2018, selling an estimated $60.7M.
- Mondrian Investment Partners's ten largest holdings make up 46% of its $3.19B portfolio in Q3 2018.
- Mondrian Investment Partners opened 3 new positions and closed 6 in Q3 2018.
- Mondrian Investment Partners's portfolio value fell 6.8% quarter-over-quarter to $3.19B.
Based on Mondrian Investment Partners's 13F filing for Q3 2018, filed 1 Nov 2018.